Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial).
Hennessy MA, Leal JP, Huang CY, Solnes LB, Denbow R, Abramson VG, Carey LA, Liu MC, Rimawi M, Specht J, Storniolo AM, Valero V, Vaklavas C, Winer EP, Krop IE, Wolff AC, Cimino-Mathews A, Wahl RL, Stearns V, Connolly RM.
Hennessy MA, et al. Among authors: solnes lb.
J Nucl Med. 2023 Nov;64(11):1690-1696. doi: 10.2967/jnumed.123.265853. Epub 2023 Aug 31.
J Nucl Med. 2023.
PMID: 37652539
Free article.